Graduates share personal stories on challenges and achievements.

Proposed bill would help support startup services at UCSF, other UC campuses.

With one drug to shut down its progression and another to undo its damage, MS doesn’t stand a chance.

More than 30 countries actively working to eliminate disease.

Risk may be almost doubled by escalating depression in the elderly, according to UC San Francisco research.

UC regents sign off on a plan to construct additional facility for UCSF's world-class program.

More common in children than autism, SPD has only recently gained recognition as a distinct neurological disorder. UCSF's Elysa Marco explains how her team's groundbreaking research may lead to a greater understanding of the condition, as well as better diagnosis and treatment.

UC San Francisco’s Jason Gestwicki describes his lab’s work developing eye drops to reverse cataracts, a potential boon to millions of people who go blind every year in developing countries because they can't afford (or have access to) the current, successful surgical treatment.

Musician Mickey Hart worked with UCSF researchers to develop representations of his brain in light and music.

Study of simian immunodeficiency virus yields insight into varied reaction to virus in humans.

Acute symptoms 50 percent more likely in study of 2,500 African-American and Latino children.

Drop in cost would make solar a major player in energy industry.